Latest chemotherapy Stories
DALLAS and NEW YORK, March 31, 2015 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
LUGANO, Switzerland, March 30, 2015 /PRNewswire/ -- First New Fixed Dose Combination Targeting Two Key Pathways Involved in CINV Helsinn, the Swiss Group
HORSHAM, Pa., March 30, 2015 /PRNewswire/ -- The U.S.
Key data confirming Cantrixil kills ovarian cancer stem cells SYDNEY, March 30, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ:NVGN) and
Patients Too Sick for Enrollment in Phase III Trial for Newly Diagnosed GBM BETHESDA, Md., March 27, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
Single-center, retrospective study evaluates Hepatic Progression Free Survival and Overall Survival after Regional Therapy NEW YORK, March 27, 2015 /PRNewswire/ -- Delcath Systems,
Researchers have developed an experimental drug to treat brain tumors by targeting the mitochondria. While it went well in mice, human trials are expected to happen very soon.
PORTLAND, Oregon, March 25, 2015 /PRNewswire/ -- Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types,
A Kirkus review highlights Dr.
A new approach to treating advanced ovarian cancer may significantly improve patients’ survival compared to standard chemotherapy regimens, according to results published online today as the
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
- To play, gamble.
- To impose upon; delude; trick; humbug; also, to joke; chaff.
- A deceitful game or trick; trickery; humbug; nonsense.